Actuate Therapeutics
Latest round
- Series B
Last raised
- Oct 2019
Total raised
- $28M
Investors
- 4
About Actuate Therapeutics
Founded in 2015 and based in Texas, US, Actuate Therapeutics, Inc. is a biopharmaceutical company that engages in the research and development of compounds for the treatment of cancer and inflammatory diseases that lead to fibrosis and neurodegeneration. As of 2024, the company is headed by its CEO Daniel M. Schmitt." Actuate Therapeutics, Inc. has granted the underwriters a 30-day option to purchase up to an additional 420,000 shares of common stock as part of the listing., respectively. Actuate's primary product, elraglusib, is a novel GSK-3 inhibitor that targets multiple molecular pathways associated with cancer growth and resistance. This drug is designed to address the limitations of traditional chemotherapy by inhibiting key immune checkpoints and regulating immune cell function. It provides cancer therapeutics with a focus on both tumor reduction and immune system modulation. Actuate Therapeutics is in the research and development phase, with revenue primarily generated through investment and partnerships.
Who invested in Actuate Therapeutics
4 investors across 2 rounds
See all investors in Actuate Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Actuate Therapeutics
Who invested in Actuate Therapeutics?
Actuate Therapeutics has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Actuate Therapeutics raised?
Actuate Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Actuate Therapeutics last raise money?
Actuate Therapeutics's most recent round on record is a Series B, in Oct 2019.
What does Actuate Therapeutics do?
Founded in 2015 and based in Texas, US, Actuate Therapeutics, Inc.
Where is Actuate Therapeutics headquartered?
Actuate Therapeutics is headquartered in Fort Worth, US.
Which VCs invest in companies like Actuate Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Actuate Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Actuate Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.